Emerging role of adipokines as mediators in atherosclerosis.
about
Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In VitroIncreased circulating ANG II and TNF-α represents important risk factors in obese saudi adults with hypertension irrespective of diabetic status and BMIRelationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients.The Impact of Full-Length, Trimeric and Globular Adiponectin on Lipolysis in Subcutaneous and Visceral Adipocytes of Obese and Non-Obese Women.Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome.Serum adiponectin level is not only decreased in metabolic syndrome but also in borderline metabolic abnormalities.Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction.L-4F Inhibits Oxidized Low-density Lipoprotein-induced Inflammatory Adipokine Secretion via Cyclic AMP/Protein Kinase A-CCAAT/Enhancer Binding Protein β Signaling Pathway in 3T3-L1 Adipocytes.Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma.Association of serum omentin-1 levels with coronary artery disease.Role of endoplasmic reticulum stress in atherosclerosis and diabetic macrovascular complications.Inflammation and reactive oxygen species in cardiovascular diseaseSerum adiponectin levels in patients with acute coronary syndromes: Serial changes and relation to infarct size.Role of omentin-1 and C-reactive protein in obese subjects with subclinical inflammation.Association of adipokines with cardiovascular risk factors in low birth weight children: a case-control study.Hyperleptinemia: implications on the inflammatory state and vascular protection in obese adolescents submitted to an interdisciplinary therapy.
P2860
Q27324561-1EA68DBF-EE98-4168-937F-EAB8852C87B1Q28484327-03789A9E-0E74-462E-9CBA-2804C56E5330Q34769904-1AC489C8-EDB1-4842-BDC2-C8B74098A156Q34785586-9C87FB68-A296-4B30-AFC7-3F62D8A8755FQ35369515-59638978-69A8-4DB4-B0ED-D5B3684E713CQ35825674-A8794457-D41F-4BD4-AE79-89228C0E490EQ35859738-F4A3F596-77A5-4726-B81E-561358F6A980Q36856589-A3C60DA9-C268-48A4-ABE4-7CF1CD66378AQ37417134-E4C270BD-44D1-4B28-BFB4-8843B3603674Q37729492-E9B4DDAA-98BC-4F64-9EF3-FC9F64F54283Q38233882-7DA3B5A0-7EC0-468C-B776-AE0F91F58FF1Q41502027-A82EA6A6-03B4-4E85-8D3C-76FFA67DD66FQ41566376-D6D61CEF-17CF-4088-A3F3-FA8971094813Q45357892-2EFEC053-CC72-406D-BD54-F11F1DFCE765Q47282540-7120F5B2-91C8-4DFF-88E3-BDB1DAD4B2ADQ47823790-D410E8F3-17D5-45E6-81EB-AC3BD355E7D3
P2860
Emerging role of adipokines as mediators in atherosclerosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Emerging role of adipokines as mediators in atherosclerosis.
@ast
Emerging role of adipokines as mediators in atherosclerosis.
@en
Emerging role of adipokines as mediators in atherosclerosis.
@nl
type
label
Emerging role of adipokines as mediators in atherosclerosis.
@ast
Emerging role of adipokines as mediators in atherosclerosis.
@en
Emerging role of adipokines as mediators in atherosclerosis.
@nl
prefLabel
Emerging role of adipokines as mediators in atherosclerosis.
@ast
Emerging role of adipokines as mediators in atherosclerosis.
@en
Emerging role of adipokines as mediators in atherosclerosis.
@nl
P2093
P2860
P356
P1476
Emerging role of adipokines as mediators in atherosclerosis.
@en
P2093
Cuihua Zhang
Hanrui Zhang
P2860
P304
P356
10.4330/WJC.V2.I11.370
P577
2010-11-01T00:00:00Z